A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody.

Source:http://linkedlifedata.com/resource/pubmed/id/19017947

J. Immunol. 2008 Dec 1 181 11 7581-92

Download in:

View as

General Info

PMID
19017947